Physician profile
Seifu M Demissie
NPI 1821256629
$3,316.33
in general payments reported to CMS, 2019-2025
13 companies · $990 in 2025
The $990 reported for 2025 was more than what 87% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $37.56 · 2021: $94.21 · 2022: $409 · 2023: $700 · 2024: $926 · 2025: $990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,416 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,416.03 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,053.67 | 2019-2025 | Fasenra, Tezspire |
| Glaxosmithkline, LLC. | $712.13 | 2020-2025 | Nucala |
| Amgen INC. | $330.35 | 2022-2025 | Tezspire |
| Jazz Pharmaceuticals INC. | $327.77 | 2022-2025 | Xywav |
| Harmony Biosciences LLC | $263.88 | 2023-2025 | Wakix |
| Regeneron Healthcare Solutions, INC. | $253.31 | 2019-2025 | Dupixent |
| Genzyme Corporation | $223.46 | 2022-2025 | |
| Electromed, INC. | $46.22 | 2019-2024 | Smartvest |
| Novartis Pharmaceuticals Corporation | $29.34 | 2019 | |
| Sobi, INC | $25.41 | 2022 | |
| Baxter Healthcare | $22.84 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Advanced Respiratory, INC | $14.57 | 2019 | |
| Philips North America LLC | $13.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seifu Demissie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.